151 related articles for article (PubMed ID: 25395431)
1. We don't prescribe statins to lower cholesterol: we prescribe statins to reduce vascular risk.
Tonelli M
J Am Soc Nephrol; 2015 May; 26(5):1001-3. PubMed ID: 25395431
[No Abstract] [Full Text] [Related]
2. Contrasting Cholesterol Management Guidelines for Adults with CKD.
Colantonio LD; Baber U; Banach M; Tanner RM; Warnock DG; Gutiérrez OM; Safford MM; Wanner C; Howard G; Muntner P
J Am Soc Nephrol; 2015 May; 26(5):1173-80. PubMed ID: 25395432
[TBL] [Abstract][Full Text] [Related]
3. New American College of Cardiology and American Heart Association cholesterol treatment guidelines: subjects with Type 2 diabetes are under treated with high-intensity statins.
Tripolt NJ; Sourij H
Diabet Med; 2014 Jul; 31(7):879-80. PubMed ID: 24612178
[No Abstract] [Full Text] [Related]
4. Lipid-lowering therapy in chronic kidney disease: is there a role for ezetimibe?
Green D; Panayotova R; Ritchie JP; O'Riordan E; McDonald J
J Ren Care; 2012 Sep; 38(3):138-46. PubMed ID: 22613701
[TBL] [Abstract][Full Text] [Related]
5. [Optimal cholesterol levels in patients in real-life. A systematic review].
Escobar C; Barrios V; Pérez de Isla L
Semergen; 2018; 44(1):42-49. PubMed ID: 29153337
[TBL] [Abstract][Full Text] [Related]
6. HDL-C: role as a risk modifier.
Barter P
Atheroscler Suppl; 2011 Nov; 12(3):267-70. PubMed ID: 22152280
[TBL] [Abstract][Full Text] [Related]
7. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
Stone NJ; Robinson JG; Lichtenstein AH; Bairey Merz CN; Blum CB; Eckel RH; Goldberg AC; Gordon D; Levy D; Lloyd-Jones DM; McBride P; Schwartz JS; Shero ST; Smith SC; Watson K; Wilson PW; Eddleman KM; Jarrett NM; LaBresh K; Nevo L; Wnek J; Anderson JL; Halperin JL; Albert NM; Bozkurt B; Brindis RG; Curtis LH; DeMets D; Hochman JS; Kovacs RJ; Ohman EM; Pressler SJ; Sellke FW; Shen WK; Smith SC; Tomaselli GF;
Circulation; 2014 Jun; 129(25 Suppl 2):S1-45. PubMed ID: 24222016
[No Abstract] [Full Text] [Related]
8. Cholesterol treatment and changes in guidelines in an academic medical practice.
Schoen MW; Salas J; Scherrer JF; Buckhold FR
Am J Med; 2015 Apr; 128(4):403-9. PubMed ID: 25460526
[TBL] [Abstract][Full Text] [Related]
9. On-treatment lipid profiles to predict the cardiovascular outcomes in ASCVD patients comorbid with chronic kidney disease - The multi-center T-SPARCLE registry study.
Ho LT; Lin FJ; Tseng WK; Yin WH; Wu YW; Li YH; Yeh HI; Chen JW; Wu CC;
J Formos Med Assoc; 2018 Sep; 117(9):814-824. PubMed ID: 29945742
[TBL] [Abstract][Full Text] [Related]
10. [Treatment with statins: lowering of cholesterol or more?].
Rutishauser J
Praxis (Bern 1994); 2006 Jan; 95(4):107-10. PubMed ID: 16485605
[No Abstract] [Full Text] [Related]
11. [Cholesterol metabolism modulators in future drug therapy for atherosclerosis].
Morozova S; Suc-Royer I; Auwerx J
Med Sci (Paris); 2005 Dec; 21 Spec No():53-8. PubMed ID: 16598906
[TBL] [Abstract][Full Text] [Related]
12. Role of ezetimibe in the management of patients with atherosclerosis.
Hamilton P
Coron Artery Dis; 2009 Mar; 20(2):169-74. PubMed ID: 19106797
[TBL] [Abstract][Full Text] [Related]
13. Simvastatin for secondary prevention of all-cause mortality and major coronary events in patients with mild chronic renal insufficiency.
Chonchol M; Cook T; Kjekshus J; Pedersen TR; Lindenfeld J
Am J Kidney Dis; 2007 Mar; 49(3):373-82. PubMed ID: 17336698
[TBL] [Abstract][Full Text] [Related]
14. Clinical determinants and treatment gaps in familial hypercholesterolemia: Data from a multi-ethnic regional health service.
Zafrir B; Jubran A; Lavie G; Halon DA; Flugelman MY; Shapira C
Eur J Prev Cardiol; 2017 May; 24(8):867-875. PubMed ID: 28186442
[TBL] [Abstract][Full Text] [Related]
15. Lipid Management Steps Forward.
Siegel JA
J S C Med Assoc; 2015 Dec-2016 Jan; 111(4):122-5. PubMed ID: 27141703
[No Abstract] [Full Text] [Related]
16. [Guidelines for the management of dyslipidemia].
Díaz Rodríguez Á;
Semergen; 2014 Sep; 40 Suppl 4():19-25. PubMed ID: 25595349
[TBL] [Abstract][Full Text] [Related]
17. Calcific aortic stenosis.
Pazianas M
N Engl J Med; 2009 Jan; 360(1):85; author reply 85-6. PubMed ID: 19118311
[No Abstract] [Full Text] [Related]
18. [An updated overview of the high intensity lipid lowering therapy in high cardiovascular risk patients].
Pedro-Botet J; Pintó X
Clin Investig Arterioscler; 2016; 28(1):19-30. PubMed ID: 26657098
[TBL] [Abstract][Full Text] [Related]
19. [The importance of cholesterol-lowering in patients after coronary artery bypass surgery].
von Hodenberg E; Breidenbach T; Melichercik J
Clin Res Cardiol; 2006 Jan; 95 Suppl 1():i78-82. PubMed ID: 16598555
[TBL] [Abstract][Full Text] [Related]
20. [New points and limits of 2013 American College of Cardiology/American Heart Association guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults].
Ye P
Zhonghua Nei Ke Za Zhi; 2014 Feb; 53(2):87-8. PubMed ID: 24767156
[No Abstract] [Full Text] [Related]
[Next] [New Search]
